Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cemtrex (CETX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cemtrex (CETX) over the last 17 years, with Q3 2025 value amounting to $6.3 million.

  • Cemtrex's Cash & Equivalents rose 1709.56% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 1709.56%. This contributed to the annual value of $6.3 million for FY2025, which is 1709.56% up from last year.
  • According to the latest figures from Q3 2025, Cemtrex's Cash & Equivalents is $6.3 million, which was up 1709.56% from $8.1 million recorded in Q2 2025.
  • Over the past 5 years, Cemtrex's Cash & Equivalents peaked at $15.6 million during Q1 2021, and registered a low of $4.0 million during Q4 2023.
  • Over the past 5 years, Cemtrex's median Cash & Equivalents value was $6.6 million (recorded in 2023), while the average stood at $8.3 million.
  • In the last 5 years, Cemtrex's Cash & Equivalents skyrocketed by 45430.61% in 2021 and then plummeted by 4465.97% in 2023.
  • Cemtrex's Cash & Equivalents (Quarter) stood at $10.3 million in 2021, then plummeted by 44.21% to $5.8 million in 2022, then tumbled by 30.37% to $4.0 million in 2023, then skyrocketed by 36.04% to $5.5 million in 2024, then rose by 16.16% to $6.3 million in 2025.
  • Its Cash & Equivalents was $6.3 million in Q3 2025, compared to $8.1 million in Q2 2025 and $6.1 million in Q1 2025.